Come up with a name for your new list and we'll add to it:
Cellective Therapeutics was acquired by
MedImmune on October 18, 2005.
Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke Univ…